Statistics
Publications
83
Citations
4.4K
H-Index
36
Active since
2007
Fengwei Tan is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in oncology, medicine, and molecular oncology.
Publications per year
2007–2025
83
83
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
Shugeng Gao, Ning Li, Shun‐Yu Gao et al. · Journal of Thoracic Oncology · 2020 · 415 citations · Full text
Pharmacy, Oncology, Pharmacotherapy +17
Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC
Bin Qiu, Wei Guo, Fan Zhang et al. · Nature Communications · 2021 · 285 citations · Full text
Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
Sijin Sun, Wei Guo, Zhen Wang et al. · Cancer Medicine · 2020 · 170 citations · Full text
Medicine, Immunology, Oncology +17
1–5 of 83